Levi & Korsinsky Files Class Action Lawsuit for Reckitt Benckiser Shareholders Affected by Alleged Fraud
Overview of the Class Action Filed by Levi & Korsinsky
On June 27, 2025, Levi & Korsinsky, LLP, announced that they have filed a class action lawsuit on behalf of shareholders of Reckitt Benckiser Group plc, trading under OTC PINK: RBGLY. The lawsuit is aimed at compensating investors adversely affected by what they believe to be securities fraud that occurred between January 13, 2021, and July 28, 2024.
Class Definition and Allegations
The legal complaints filed allege that Reckitt Benckiser misled investors by issuing false statements regarding the safety of their cow’s milk-based infant formula, Enfamil. Specifically, it has been claimed that the company concealed evidence linking the formula to an increased risk of necrotizing enterocolitis (NEC) in preterm infants. Due to this alleged negligence, investors are now left grappling with significant financial losses.
Legal representatives assert that Reckitt Benckiser's executives failed to inform shareholders about the potential negative impact of these allegations on sales and possible legal claims. The false assurances provided by the company regarding their overall business health were thus materially misleading. This, in turn, raises questions about Reckitt’s business operations and financial stability during the stated period.
Next Steps for Investors
Investors who believe they have been affected by Reckitt Benckiser’s alleged misconduct have until August 4, 2025, to request to be appointed as lead plaintiff in the case. However, it is essential to note that participation in any potential settlement does not require serving in this position, making it accessible for all investors impacted.
No Cost to Participate
For affected shareholders, participating in this class action carries no upfront costs. Levi & Korsinsky provides assurance that any class member can pursue compensation without incurring out-of-pocket expenses. The firm emphasizes that there is no cost or obligation for investors to participate in the proceedings.
Why Choose Levi & Korsinsky
Levi & Korsinsky prides itself on a robust track record, having secured hundreds of millions in settlements for distressed shareholders over the past two decades. The firm’s expertise in complex securities litigation, powered by over 70 dedicated professionals, earmarks it as a prominent player in this legal realm. Notably, it has consistently ranked as one of the top firms in the field for seven consecutive years, reflecting its longstanding commitment to its clients.
Contact Information
For any investors concerned about the allegations or those seeking more information about the class action, they can reach out to Levi & Korsinsky directly. Contact details include:
This filing represents a critical moment for investors to hold Reckitt Benckiser accountable for its alleged misrepresentations. As the legal proceedings unfold, impacted shareholders should monitor developments closely and consider their options for participation in the case.
On June 27, 2025, Levi & Korsinsky, LLP, announced that they have filed a class action lawsuit on behalf of shareholders of Reckitt Benckiser Group plc, trading under OTC PINK: RBGLY. The lawsuit is aimed at compensating investors adversely affected by what they believe to be securities fraud that occurred between January 13, 2021, and July 28, 2024.
Class Definition and Allegations
The legal complaints filed allege that Reckitt Benckiser misled investors by issuing false statements regarding the safety of their cow’s milk-based infant formula, Enfamil. Specifically, it has been claimed that the company concealed evidence linking the formula to an increased risk of necrotizing enterocolitis (NEC) in preterm infants. Due to this alleged negligence, investors are now left grappling with significant financial losses.
Legal representatives assert that Reckitt Benckiser's executives failed to inform shareholders about the potential negative impact of these allegations on sales and possible legal claims. The false assurances provided by the company regarding their overall business health were thus materially misleading. This, in turn, raises questions about Reckitt’s business operations and financial stability during the stated period.
Next Steps for Investors
Investors who believe they have been affected by Reckitt Benckiser’s alleged misconduct have until August 4, 2025, to request to be appointed as lead plaintiff in the case. However, it is essential to note that participation in any potential settlement does not require serving in this position, making it accessible for all investors impacted.
No Cost to Participate
For affected shareholders, participating in this class action carries no upfront costs. Levi & Korsinsky provides assurance that any class member can pursue compensation without incurring out-of-pocket expenses. The firm emphasizes that there is no cost or obligation for investors to participate in the proceedings.
Why Choose Levi & Korsinsky
Levi & Korsinsky prides itself on a robust track record, having secured hundreds of millions in settlements for distressed shareholders over the past two decades. The firm’s expertise in complex securities litigation, powered by over 70 dedicated professionals, earmarks it as a prominent player in this legal realm. Notably, it has consistently ranked as one of the top firms in the field for seven consecutive years, reflecting its longstanding commitment to its clients.
Contact Information
For any investors concerned about the allegations or those seeking more information about the class action, they can reach out to Levi & Korsinsky directly. Contact details include:
- - Email: [email protected]
- - Phone: (212) 363-7500
- - Address: 33 Whitehall Street, 17th Floor, New York, NY 10004
This filing represents a critical moment for investors to hold Reckitt Benckiser accountable for its alleged misrepresentations. As the legal proceedings unfold, impacted shareholders should monitor developments closely and consider their options for participation in the case.
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.